Biotechs and banks lead S&P 500 to milestone

Summary: Equities were in favor, thanks to deals between drug maker Roche and biotech company InterMune along with plans of a hook up between Burger King and Tim Hortons, leading the S&P to break above 2,000 for the first time. Conway G. Gittens reports.